Azitra Overview

  • Founded
  • 2014
Founded
  • Status
  • Private
  • Employees
  • 5
Employees
  • Latest Deal Type
  • Series A
  • Latest Deal Amount
  • $14M
Latest Deal Amount
  • Investors
  • 12

Azitra General Information

Description

Developer of microbiome-based novel therapeutics intended to treat skin conditions and diseases. The company leverages microbiological bacteria strains technology to facilitate the treatment of eczema, ichthyosis vulgaris, inflammatory skin, irritated skin and orphan skin diseases including Netherton syndrome, enabling dermatologists to treat patients with chronic and acute skin disorders.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Primary Office
  • 400 Farmington Avenue
  • Farmington, CT 06032
  • United States
+1 (860) 000-0000

Azitra Timeline

2017201820192020
Financing RoundFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Azitra Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Early Stage VC (Series A) 15-Oct-2019 $14M 000.00 Completed Pre-Clinical Trials
9. Grant 09-Apr-2019 00000 000.00 Completed Pre-Clinical Trials
8. Seed Round 29-Mar-2019 000 000.00 Completed Pre-Clinical Trials
7. Early Stage VC (Series A1) 01-Mar-2019 00.00 00.00 000.00 Completed Pre-Clinical Trials
6. Grant 01-Aug-2018 00000 00.00 Completed Pre-Clinical Trials
5. Early Stage VC (Series A) 17-Mar-2017 00.00 00.00 00.00 Completed Pre-Clinical Trials
4. Grant 01-Jan-2017 00000 Completed Pre-Clinical Trials
3. Accelerator/Incubator Completed Pre-Clinical Trials
2. Grant 01-Sep-2016 Completed Pre-Clinical Trials
1. Accelerator/Incubator $1K Completed Startup
To view Azitra’s complete valuation and funding history, request access »

Azitra Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A1 000,000 00.000000 00 000.0 000.0 00 000.0 00.000
Series A 000,000 00.000000 00 000.00 000.00 00 000.00 00.000
To view Azitra’s complete cap table history, request access »

Azitra Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of microbiome-based novel therapeutics intended to treat skin conditions and diseases. The company leverages m
Biotechnology
Farmington, CT
5 As of 2016
000.00
00000000000 000.00

0-000000

ectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim
0000000000000
Beerse, Belgium
00.000
0.00 0000-00-00
00000000000 00.000

00000000

veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aut
0000 000000000
San Diego, CA
0 As of 0000
00.00
0000000000 0 00.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Azitra Competitors (5)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
S-Biomedic Venture Capital-Backed Beerse, Belgium 00.000 00000000000 00.000
00000000 000000000 Venture Capital-Backed San Diego, CA 0 00.00 0000000000 0 00.00
00000000 000000000 Corporate Backed or Acquired 000.00 000000&0
00000 00000 Venture Capital-Backed San Francisco, CA 0 00.000 000000000 00.000
0000 0000000000000 Formerly PE-Backed West Chester, PA 000000&0
To view Azitra’s complete competitors history, request access »

Azitra Executive Team (6)

Name Title Board Seat Contact Info
Richard Andrews President, Chief Executive Officer and Board Member
Jeanne Bertonis Chief Operating Officer
David Dodds Ph.D Chief Technical Officer
Mark Sampson Ph.D Chief Scientific Officer
Travis Whitfill Co-Founder, Chief Science Officer, Executive Director of Advanced Technology and Board Member
You’re viewing 5 of 6 executive team members. Get the full list »

Azitra Board Members (6)

Name Representing Role Since
Cain McClary MD KdT Ventures Board Member 000 0000
Daniel Wagner Connecticut Innovations Board Member 000 0000
Richard Andrews Azitra President, Chief Executive Officer and Board Member 000 0000
Stella Robertson Ph.D Bios Partners Board Member 000 0000
Travis Whitfill Azitra Co-Founder, Chief Science Officer, Executive Director of Advanced Technology and Board Member 000 0000
You’re viewing 5 of 6 board members. Get the full list »

Azitra Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Azitra Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Godfrey Capital Family Office Minority 000 0000 000000 0
Connecticut Innovations Venture Capital Minority 000 0000 000000 0
KdT Ventures Venture Capital Minority 000 0000 000000 0
National Institutes of Health Government 000 0000 000000 0
United States Department of Defense Government 000 0000 000000 0
You’re viewing 5 of 12 investors. Get the full list »